NVIDIA Corporation vs. Telix Pharmaceuticals Limited American Depositary Shares
NVDA
NVIDIA Corporation
$219.16 +2.46%
VS TLXTelix Pharmaceuticals Limited American Depositary Shares
$11.83 -7.79%
Telix Pharmaceuticals Limited American Depositary Shares (TLX) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| NVDA | TLX | |
|---|---|---|
| Market Cap | $5.17 trillion | $4.02 billion |
| Revenue (TTM) | $302.97 billion | — |
| Net Income (TTM) | $192.88 billion | — |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| NVDA | TLX | |
|---|---|---|
| P/E Ratio | 27.71 | — |
| Price / Book | 22.56 | — |
| Price / Sales | 17.05 | — |
NVDA and TLX split the valuation factors evenly.
Profitability
| NVDA | TLX | |
|---|---|---|
| Net Margin | 63.66% | — |
| Return on Equity | 84.23% | — |
NVDA and TLX split the profitability factors evenly.
Dividend
| NVDA | TLX | |
|---|---|---|
| Dividend Yield | 0.46% | 1.18% |
| Payout Ratio | 12.64 | — |
TLX leads on 1 of 1 dividend factors.
Risk & Sentiment
| NVDA | TLX | |
|---|---|---|
| Short Interest | 0.07% | 0.00% |
TLX leads on 1 of 1 risk & sentiment factors.
Dig deeper: NVDA overview, NVDA financials, TLX overview, TLX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.